General experimental methods
Common chemicals and solvents in addition to 2-cyanoethyl diisopropylphosphoramidochloridite were purchased from commercial sources and used without further purification. Anhydrous solvents and deuterated solvents (CDCl 3 ) were obtained from reputable sources and used as received.
Phosphodiesterase I from Crotalus adamanteus venom (SNVPD) and
Phosphodiesterase II from bovine spleen were purchased from Sigma-Aldrich and used without further purification. Calf intestinal alkaline phosphatase and Turbo Dicer enzyme were purchased from Invitrogen and Genlantis, respectively.
All reactions were carried out under argon atmosphere in oven-dried glassware. Thinlayer chromatography was carried out on aluminium-backed Silica-Gel 60 F 254 plates.
Column chromatography was performed using Silica Gel (60 Å , 230 x 400 mesh).
NMR spectra were measured on Varian Mercury-400, Varian-500 or Varian-500 instruments. Chemical shifts are given in parts per million (ppm); J values are given in hertz (Hz). All spectra were internally referenced to the appropriate residual undeuterated solvent.
HRMS and ESI spectra were performed on a LC/MSD-TOF (Agilent Technologies) mass spectrometer.
MALDI-TOF spectra were performed using a Perspective Voyager DETMRP mass spectrometer, equipped with nitrogen laser at 337 nm using a 3ns pulse. The matrix used contained 2,4,6-trihydroxyacetophenone (THAP, 10 mg/mL in CH 3 CN/water 1:1) and ammonium citrate (50 mg/mL in water).
Scheme S1. Synthesis of N-alkyl-N dimeric nucleosides BCn

3'-O-tert-Butyldimethylsilyl-5'-O-(4,4'-dimethoxytrityl)thymidine (S1):
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3'-O-Acetyl-5'-O-tert-butyldimethylsilylthymidine (S4):
1-{N 4 -[3'-O-tert-butyldimethylsilyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-5-methylcytidylyl]}-2-[N 4 -(3'-O-acetyl-5'-O-tert-butyldimethylsilyl-2'-deoxy-
1-{N 4 -[3'-O-tert-butyldimethylsilyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-5-methylcytidylyl]}-2-[N 4 -(5'-O-tert-butyldimethylsilyl-2'-deoxy-5-methylcytidylyl)]-hexane (S8b):
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All the frequencies were normalized. A Bonferroni test was conducted to evaluate BC6 and 7 nt loops (RNAs 2b and 5) to the unmodified control (siRNA I) and to evaluate 7 nt loops (RNA 5) to BC6 loops (RNA 2b). *** (P < 0.001) and **** (P < 0.0001) indicates a significant change in
Renilla expression from unmodified siRNA 1. ### (P < 0.001) indicates a significant change in Renilla expression from 7 nt-loop dumbbell 5. 
